immunolog
implic
pregnanc
motiv
immunologist
half
centuri
variou
mechan
propos
explain
reject
antigen
foreign
fetu
prevent
absenc
classic
mhc
class
molecul
regulatori
cell
expans
specif
suppress
paternallyderiv
antigen
pregnanc
also
associ
reduc
patholog
allevi
symptom
inflammatori
autoimmun
diseas
multipl
sclerosi
rheumatoid
arthriti
profound
immunolog
chang
diseas
state
pregnanc
suggest
exist
broad
impact
immun
regul
specif
fetal
antigen
empir
evid
suggest
pregnant
women
fair
poorli
respons
certain
pathogen
challeng
includ
listeria
monocytogen
malaria
sar
coronaviru
varicella
zoster
rhinoviru
influenza
viru
among
other
increas
risk
sever
influenza
infect
particular
public
health
concern
pregnanc
acknowledg
risk
factor
sever
complic
influenza
viru
infect
nearli
centuri
observ
everi
major
influenza
pandem
includ
pandem
implic
sever
influenza
infect
pregnanc
life
threaten
mother
child
significantli
increas
risk
cardiopulmonari
event
report
mortal
mother
high
moreov
consequ
fetu
rang
behavior
alter
low
birthweight
preterm
birth
spontan
abort
signific
effort
put
determin
safeti
efficaci
vaccin
pregnanc
well
efficaci
neuraminidas
inhibitor
deeper
understand
chang
matern
immun
pregnanc
need
order
devis
adequ
therapeut
strategi
mani
clinic
studi
perform
empir
defin
increas
sever
influenza
infect
pregnanc
safeti
ethic
reason
studi
conduct
set
without
viral
challeng
reli
observ
made
onset
symptom
although
earlier
work
establish
increas
mortal
influenza
infect
pregnanc
observ
mous
model
recent
work
primarili
focus
character
associ
morbid
lethal
infect
littl
insight
immun
impact
earli
infect
increas
morbid
due
influenza
infect
typic
associ
third
trimest
pregnanc
correl
well
highest
level
circul
estrogen
estrogen
long
known
possess
potent
immunomodulatori
effect
variou
model
diseas
propos
therapeut
use
clinic
situat
although
pregnanc
level
estrogen
associ
reduc
level
immunemedi
morbid
sever
morbid
hallmark
influenza
infect
pregnanc
sought
reconcil
observ
determin
role
high
level
estrogen
play
influenza
infect
pregnanc
develop
model
influenza
infect
pregnant
mice
document
major
chang
antivir
respons
moreov
use
implant
hormon
pellet
determin
estrogen
alon
abl
recapitul
mani
key
alter
observ
pregnanc
estrogen
treatment
lead
earli
reduct
cytokin
product
particular
typei
interferon
ifn
impact
downstream
activ
adapt
immun
addit
estrogen
treatment
compromis
effect
antigenspecif
cytotox
ultim
defici
result
significantli
delay
viral
clearanc
pregnant
anim
highlight
presenc
antiinflammatori
mechan
context
enhanc
morbid
determin
respons
influenza
viru
infect
pregnanc
challeng
mice
gestat
day
nonpregn
control
aerosol
viru
control
chamber
peak
viral
titer
reach
set
mice
day
postinfect
dpi
figur
describ
previous
dpi
nonpregn
mice
show
significantli
lower
pulmonari
viral
titer
suggest
abl
clear
viru
effici
pregnant
counterpart
weight
gain
result
pregnanc
outpac
potenti
weight
loss
incur
infect
although
pregnant
infect
mice
lose
weight
compar
mock
control
weight
loss
delay
approxim
day
compar
weight
loss
nonpregn
control
suggest
immuneassoci
morbid
delay
pregnant
anim
figur
signific
morbid
readili
evid
measur
gestat
health
number
fetus
per
mother
effect
infect
model
figur
fetus
influenzainfect
mice
fail
achiev
weight
counterpart
mockinfect
mother
nearli
weight
control
figur
length
gestat
also
significantli
impact
infect
influenza
viru
infect
pregnant
mice
undergo
labor
much
earlier
mockinfect
control
figur
mock
infect
pregnant
mice
continu
gestat
beyond
bound
experi
infect
mice
univers
deliv
pup
deliv
influenzainfect
mother
therefor
prematur
addit
underweight
gestat
age
result
reinforc
evid
viabil
pregnanc
neg
impact
infect
influenza
viru
signific
burden
born
fetu
seen
clinic
situat
clinic
incid
influenza
infect
nonleth
want
model
viral
infect
milder
patholog
extrem
virul
use
establish
morbid
lethal
wildtyp
mice
nonleth
infect
model
made
use
reassort
mouseadapt
viru
infect
pregnant
anim
viru
lead
full
recoveri
significantli
pronounc
delay
viral
clearanc
figur
data
suggest
despit
signific
morbid
associ
fetal
gestat
pregnant
mice
impair
abil
control
influenza
viru
infect
lethal
nonleth
model
given
well
document
effect
sex
hormon
immun
modul
well
increas
attent
estradiol
receiv
modul
diseas
pregnanc
decid
investig
contribut
pregnancylevel
independ
hormon
immunolog
modul
made
use
biodegrad
pellet
implant
beneath
skin
releas
serum
level
found
third
trimest
level
experi
figur
pregnant
anim
track
weight
loss
estradioltr
mice
use
virul
viru
figur
initi
weight
loss
nearli
ident
stabil
mice
placebopellet
mice
continu
lose
weight
throughout
latter
part
infect
observ
compat
result
pregnant
mice
found
signific
weight
loss
nonpregn
control
viral
growth
clearanc
mice
mirror
pregnanc
extrem
well
figur
use
viru
analyz
viral
clearanc
found
peak
titer
achiev
group
viru
clear
placebopellet
mice
clearanc
delay
mice
taken
togeth
data
support
hypothesi
least
partial
respons
delay
viral
clearanc
found
pregnant
anim
one
critic
earli
signal
event
influenza
infect
releas
typei
interferon
ifn
previous
demonstr
abl
significantli
impair
typei
interferon
signal
human
dendrit
cell
order
extend
observ
measur
transcript
interferonstimul
gene
isg
quantit
realtim
pcr
rna
collect
whole
lung
infect
observ
signific
earli
impair
pathway
pregnant
estrogentr
mice
figur
deficit
mrna
express
also
activ
downstream
isg
suggest
signific
biolog
relev
impair
ifn
protein
express
previous
shown
interferon
signal
play
import
role
tissu
outsid
lung
antivir
instruct
peripher
leukocyt
import
effect
control
viral
infect
featur
robust
immun
respons
use
spleen
tissu
direct
contact
viru
detect
impair
isg
upregul
peripheri
figur
data
suggest
cytokinemedi
earli
immun
activ
ineffici
pregnant
anim
elimin
possibl
estrogen
treatment
interfer
interferon
signal
pathway
addit
interferon
induct
treat
splenocyt
directli
murin
figur
found
effect
ifn
signal
order
dissect
mechan
alter
immun
respons
pregnanc
collect
whole
lung
digest
throughout
infect
analysi
elisa
observ
sever
key
earli
cytokin
express
pregnant
mice
figur
includ
observ
reduc
express
earli
infect
well
decreas
express
chemokin
kc
import
note
time
point
detect
differ
viral
load
repeat
experi
use
estrogen
model
observ
similar
modul
mani
cytokin
figur
kc
express
lung
influenza
infect
mice
compar
placebo
control
result
suggest
model
establish
signific
antiinflammatori
environ
critic
earli
time
point
infect
given
signific
chang
observ
earli
cytokin
chemokin
express
investig
whether
chang
lead
variat
migratori
kinet
earli
immun
mediat
observ
signific
differ
absolut
number
cell
infiltr
lung
tissu
infect
pregnant
figur
mice
data
shown
found
differ
popul
natur
killer
cell
neutrophil
mhcii
cell
repres
mixtur
activ
exud
macrophag
dendrit
cell
infiltr
monocytederiv
cell
order
determin
whether
emigr
lung
impair
investig
number
dendrit
cell
drain
mediastin
lymph
node
key
time
point
infect
found
signific
differ
pregnant
mice
nonpregn
control
figur
mice
placebo
control
data
shown
next
analyz
whether
function
cell
migrat
mediastin
lymph
node
impair
found
strongli
reduc
level
express
cell
critic
earli
time
point
infect
pregnanc
figur
estrogentreat
figur
suggest
defici
proper
dc
matur
matur
state
dc
time
point
critic
junction
bridg
innat
adapt
immun
upregul
express
well
marker
activ
extrem
sensit
ifn
signal
adapt
immun
respons
critic
effici
clearanc
viral
infect
particular
import
activ
cytotox
cell
order
determin
whether
function
defici
adapt
immun
may
account
delay
viral
clearanc
made
use
vivo
cytotox
assay
assay
anim
infect
influenza
viru
bear
model
antigen
siinfekl
cytotox
cell
endogen
gener
toward
peptid
infect
two
popul
target
splenocyt
adopt
transfer
differenti
label
fluoresc
dye
incub
either
siinfekl
irrelev
peptid
specif
lysi
antigenbear
popul
calcul
compar
rel
proport
two
target
popul
adopt
transfer
figur
observ
signific
reduct
antigenspecif
cytotox
pregnant
figur
estrogentr
figur
anim
differ
repres
delay
abil
pregnant
mice
clear
antigen
specif
target
next
use
intracellular
cytokin
stain
techniqu
determin
effect
estrogen
granzym
b
product
cell
infect
granzym
b
serin
proteas
serv
import
role
cell
cytotox
despit
fact
viru
present
mice
found
signific
reduct
granzym
b
product
intracellular
cytokin
stain
figur
order
determin
whether
cytokin
signal
cell
broadli
affect
also
measur
product
common
measur
cell
activ
level
equival
placebo
estrogen
treatment
figur
result
suggest
observ
strongli
reduc
granzym
b
level
impair
cytotox
lungmigr
cell
capabl
secret
equival
level
next
investig
antigenspecif
prolif
respons
anim
infect
viru
adopt
transfer
cfselabel
oti
cell
transgen
cytotox
cell
specif
siinfekl
antigen
analyz
drain
lymph
node
cfse
dilut
found
fewer
cell
prolifer
estrogen
treat
mice
figur
cell
prolifer
underw
fewer
divis
placebotr
counterpart
figur
result
consist
find
immatur
dendrit
cell
lymph
node
earli
time
point
addit
delay
prolifer
migrat
total
influenzaspecif
cell
infect
lung
delay
infect
figur
observ
correl
well
observ
delay
viral
clearanc
similarli
antigen
specif
cell
drain
lymph
node
continu
reduc
estrogentr
anim
figur
total
number
cell
signific
reduc
drain
lymph
node
like
reflect
larg
number
cell
present
lymphoid
tissu
order
distinguish
effect
estrogen
delay
cell
activ
antigen
present
cell
effect
independ
antigen
present
use
singleshot
model
singl
dose
administ
infect
mice
prior
adopt
transfer
target
cell
dose
suffici
partial
replic
defect
cytotox
observ
mice
figur
therefor
impair
cell
cytotox
dc
stimul
occur
taken
togeth
data
suggest
two
mechan
cytotox
cell
defici
first
involv
delay
prolifer
migrat
antigenspecif
cytotox
cell
lung
second
involv
function
effect
estrogen
treatment
occur
activ
cell
replic
short
period
time
treatment
establish
model
influenza
infect
pregnanc
order
determin
mechan
intervent
strategi
primari
import
pandem
outbreak
reestablish
risk
sever
morbid
increas
mortal
influenza
exposur
present
pregnant
women
especi
second
third
trimest
significantli
elev
mortal
report
mous
model
use
aerosol
model
infect
abl
detect
quantifi
clinic
relev
increas
morbid
independ
lethal
notabl
fetal
pup
found
significantli
underweight
deliv
prematur
consist
clinic
observ
addit
measur
morbid
also
observ
evid
antiinflammatori
phenotyp
pregnant
mice
viral
clearanc
delay
pregnanc
use
lethal
nonleth
infect
addit
weight
loss
pregnant
mice
attenu
delay
alter
patholog
respons
influenza
viru
infect
pregnanc
like
mediat
multipl
factor
includ
chang
sex
hormon
increas
cardiopulmonari
demand
focus
impact
pregnancylevel
estrogen
welldefin
impact
immun
function
estrogen
particularli
interest
immun
modul
describ
bimod
effect
immun
circul
level
estrogen
femal
mice
associ
stimul
immun
function
gener
includ
exacerb
influenza
viru
pathogenesi
account
rel
suscept
influenza
viru
infect
nonpregn
femal
compar
male
effect
abolish
gonadectomi
gonadallyintact
femal
use
studi
order
directli
compar
pathogenesi
pregnanc
highdos
estrogentreat
healthi
wildtyp
femal
high
level
estrogen
hand
associ
antiinflammatori
phenotyp
includ
context
influenza
viru
infect
directli
link
suscept
pregnant
femal
high
morbid
highdos
estrogen
treatment
use
allevi
symptom
model
rheumatoid
arthriti
multipl
sclerosi
respons
clinic
observ
show
reduct
symptom
pregnant
women
diseas
excess
immun
respons
mediat
much
patholog
associ
influenza
viru
pregnancyspecif
morbid
also
associ
inflamm
includ
prematur
parturit
antiinflammatori
treatment
prevent
loss
pregnanc
block
administ
antiinflammatori
cytokin
shown
reduc
morbid
addit
placenta
shown
employ
neg
regulatori
mechan
aim
reduc
inflammatori
cytokin
signal
given
well
describ
antiinflammatori
phenotyp
estrogen
specif
high
level
estrogen
associ
pregnanc
sought
investig
role
estrogen
play
context
increas
morbid
influenza
infect
pregnanc
group
report
increas
morbid
influenza
infect
pregnanc
antiinflammatori
mechan
context
infect
extens
character
context
diseas
fetal
reject
focu
morbid
mous
model
influenza
viru
infect
pregnanc
often
reli
high
dose
intranas
inoculum
pathogen
viru
strain
pandem
strain
use
model
morbid
elev
mortal
low
fetal
birth
weight
observ
clinic
observ
preterm
deliveri
report
mous
model
observ
one
studi
despit
increas
cytokin
level
addit
proinflammatori
cytokin
phenotyp
report
model
delay
viral
clearanc
often
support
although
report
often
focu
event
late
infect
reflect
diverg
viral
kinet
concern
model
use
highli
pathogen
intranas
inocul
may
adequ
model
clinic
present
influenza
viru
infect
obscur
relev
phenotyp
aerosol
infect
close
model
clinic
diseas
abl
replic
clinic
observ
influenza
infect
pregnanc
focus
earli
cytokin
event
within
first
onset
immun
model
inflammatori
event
broad
impact
outcom
immun
serv
best
indic
earli
inflamm
make
use
model
infect
use
pregnancylevel
abl
measur
impact
immun
independ
pregnancyassoci
variabl
addit
demonstr
similar
delay
viral
clearanc
estrogentr
anim
also
protect
weight
loss
experienc
placebo
control
clear
estrogen
may
protect
mice
weight
loss
associ
influenza
infect
like
mechan
may
decreas
cytokineassoci
cachexia
pregnant
estrogentr
anim
earli
cytokin
respons
reduc
estrogen
link
modul
cytokin
signal
antagon
pathway
sourc
often
disagre
degre
direct
chang
depend
concentr
estrogen
model
organ
method
stimul
inde
saw
strong
trend
toward
elev
level
chemokin
kc
steadi
state
pregnanc
follow
signific
deficit
kc
express
upon
infect
complex
regul
highlight
elabor
mechan
involv
estrogen
signal
pregnanc
present
addit
layer
complex
cytokin
regul
sever
hormon
circul
pregnanc
immunolog
activ
includ
progesteron
prolactin
observ
ident
regul
cytokin
pregnanc
estrogentreat
hormon
may
account
variat
overlap
remain
signific
model
demonstr
defect
earli
immun
respons
overexpress
sever
regul
cytokin
includ
associ
morbid
influenza
infect
spontan
pregnanc
loss
abil
estrogen
suppress
cytokin
express
propos
protect
influenza
viru
pathogenesi
inde
may
estrogen
play
protect
role
pregnanc
mute
earli
cytokin
respons
would
otherwis
threaten
fetal
develop
enhanc
morbid
experienc
pregnanc
may
reli
failur
clear
viru
follow
impair
immun
respons
prolong
infect
may
result
late
cytokin
respons
trigger
prematur
deliveri
signific
morbid
delay
weight
loss
pregnant
anim
support
hypothesi
late
develop
induc
patholog
altern
prolong
infect
may
lead
signific
lung
damag
other
report
delay
lung
repair
pregnanc
lead
signific
cardiopulmonari
demand
pregnanc
may
contribut
morbid
typei
ifn
play
critic
role
earli
immun
respons
influenza
impair
pathway
pregnanc
implic
signific
alter
respons
viru
transcript
prototyp
marker
earli
typei
interferon
express
found
significantli
reduc
model
find
evid
estrogen
treatment
interf
downstream
signal
pathway
suggest
effect
mediat
reduc
typei
interferon
express
isg
level
reduc
lung
addit
peripheri
import
observ
interferon
signal
peripheri
necessari
effici
antivir
immun
reduct
well
conserv
human
model
treatment
pregnanc
mechan
interact
estrogen
typei
ifn
induct
pathway
current
understood
could
lead
signific
insight
onset
inflamm
pregnant
anim
abl
control
earli
viru
titer
well
wildtyp
counterpart
despit
reduc
level
interferon
influenza
viru
power
inhibitor
inflamm
function
counteract
earli
check
viral
growth
like
minim
impact
interferon
defici
earliest
time
point
interferon
signal
also
play
import
role
activ
matur
antigenbear
dendrit
cell
serv
bridg
innat
adapt
immun
pregnancylevel
estrogen
abl
interfer
proper
dendrit
cell
matur
reduc
level
costimulatori
molecul
particularli
relev
role
cell
activ
primari
goal
dendrit
cell
matur
effici
initi
adapt
immun
particular
initi
prolifer
antigenspecif
cell
expect
observ
signific
estrogenassoci
delay
cell
prolifer
lymph
node
significantli
reduc
number
antigenspecif
cytotox
cell
lung
lymph
node
number
eventu
recov
correl
nice
kinet
viral
clearanc
model
observ
phenotyp
result
delay
cell
recruit
lung
time
observ
critic
observ
made
late
infect
may
reflect
phenotyp
may
explain
other
fail
note
signific
differ
number
cytotox
cell
similar
model
dysregul
interferon
function
link
delay
appropri
activ
cytotox
cell
delay
viral
clearanc
addit
experienc
delay
prolifer
migrat
cell
function
compromis
cytotox
decreas
vivo
cytotox
assay
granzym
b
level
strongli
reduc
lung
infect
mice
interestingli
express
cell
unchang
suggest
cell
reach
lung
least
partial
activ
even
function
compromis
singl
dose
estrogen
administ
immedi
prior
encount
target
cell
suffici
impair
cytotox
function
suggest
effect
entir
mediat
ineffici
dendrit
cell
stimul
estrogen
signal
pathway
associ
lysosom
biogenesi
cytotox
cell
may
repres
relev
mechan
notabl
two
mechan
impair
adapt
immun
observ
first
involv
delay
prolifer
drain
lymph
node
account
delay
migrat
lung
mechan
like
product
weak
earli
interferon
signal
event
impair
antigen
present
cell
prolifer
activ
addit
function
compromis
second
mechan
independ
antigen
present
least
partial
respons
defici
cytotox
function
mechan
rapid
onset
observ
within
hour
estrogen
treatment
mechan
like
account
observ
decreas
granzym
b
product
effect
level
cell
although
pregnanc
complex
immunolog
state
clear
estrogen
play
key
role
initi
estrogen
reduc
earli
cytokin
respons
may
function
protect
cytokineassoci
morbid
earli
recruit
leukocyt
equival
earli
viral
titer
control
equal
well
pregnant
wild
type
mice
key
deficit
appear
prime
dendrit
cell
migrat
lung
lymph
node
initi
cell
expans
disrupt
interferon
signal
lead
suboptim
cell
activ
delay
viral
clearanc
estrogen
also
appear
impair
cell
cytotox
independ
dendrit
cell
activ
current
clear
antiinflammatori
effect
impact
viabil
pregnanc
particularli
fetal
develop
prematur
deliveri
evid
suggest
may
play
protect
role
deficit
viral
clearanc
prolong
exposur
infect
may
act
stressor
trigger
delay
morbid
despit
antiinflammatori
effect
estrogen
also
clear
whether
prolong
infect
signific
impact
morbid
absent
pregnanc
would
case
hormon
treatment
key
question
requir
studi
establish
novel
model
overwhelm
clinic
valu
understand
mechan
contribut
sex
hormon
immun
modul
pregnanc
anim
model
describ
report
allow
control
infect
condit
detail
observ
earli
event
infect
understand
mechan
immunolog
outcom
pregnanc
particularli
role
steroid
hormon
may
lead
develop
therapeut
option
protect
women
children
patient
receiv
hormon
replac
therapi
establish
tenet
hormon
mediat
immun
modul
may
provid
testabl
hypothes
treatment
autoimmun
diseas
multipl
sclerosi
anim
work
conduct
agreement
approv
protocol
institut
anim
care
use
committe
iacuc
mount
sinai
school
medicin
protocol
number
accord
guidelin
guid
care
use
laboratori
anim
nation
institut
health
program
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
aaalac
wild
type
transgen
oti
syngen
pregnant
mice
purchas
jackson
laboratori
bar
harbor
time
pregnant
mice
deliv
allow
two
day
rest
commenc
experi
nonpregn
mice
age
match
time
pregnant
mice
wildtyp
mice
implant
placebo
estrogen
pellet
purchas
innov
research
america
estrogen
pellet
contain
design
releas
surgeri
perform
day
prior
infect
mice
anesthet
avertin
tribromoethanol
acro
organ
shave
behind
right
ear
pellet
implant
via
small
incis
shoulder
ear
secur
surgic
clip
mice
monitor
sign
infect
experi
use
singl
dose
estradiol
mice
receiv
singl
subcutan
inject
water
solubl
sigma
six
hour
prior
receiv
target
cell
vivo
cytotox
assay
anim
hous
specif
pathogenfre
condit
influenza
viru
strain
recombin
propag
embryon
egg
viru
titer
determin
tissu
cultur
infect
assay
previous
describ
briefli
lung
extract
homogen
pbsgelatin
frozen
dri
iceethanol
storag
presenc
viru
detect
infect
mdck
cell
dilut
presenc
trypsin
presenc
viru
measur
test
presenc
hemagglutin
chicken
red
blood
cell
limit
detect
assay
approxim
per
lung
mice
infect
use
inhal
exposur
system
glasscol
usa
viru
dilut
pb
obtain
solut
solut
place
glass
nebul
aerosol
total
exposur
min
lead
infect
rate
describ
previous
estim
infecti
particl
passiv
inhal
period
mock
infect
anim
expos
aerosol
pb
lung
spleen
indic
time
point
homogen
trizol
reagent
invitrogen
rna
isol
indic
manufactur
convert
cdna
rtpcr
use
transcriptor
first
strand
cdna
synthesi
system
roch
qpcr
reaction
perform
use
lightcycl
ii
roch
reaction
normal
three
housekeep
gene
previous
describ
follow
primer
use
studi
forward
aggtgacagcattgcttctg
revers
gctgcctcaacacctcaac
forward
tgcctttgtgcactggtatg
revers
ctggagcagtttgacgacac
forward
cgtgacgaagatgaagatgc
revers
gcacattgaatcgcacagtc
forward
agatgtcctcaactgctctc
revers
agattcactaccagtcccag
forward
caactggaatcctcctggaa
revers
ggctctcctcagaggtatca
rigi
forward
cagacagatccgagacacta
revers
tgcaagacctttggccagtt
lung
perfus
cold
pb
contain
edta
immedi
ground
hank
buffer
salin
solut
contain
edta
fb
use
gentlemac
tissu
dissoci
miltenyi
biotec
mediastin
lymph
node
mechan
disrupt
tissu
incub
collagenas
liberas
type
iii
roch
dnase
invitrogen
min
collagenas
inactiv
steril
hbss
contain
fb
suspens
pass
strainer
suspens
treat
red
blood
cell
lysi
buffer
bd
bioscienc
resuspend
hbss
contain
fcreceptor
block
bd
bioscienc
total
cell
count
attain
hemocytomet
cell
stain
antibodi
multipl
surfac
antigen
mhcii
intracellular
cytokin
stain
total
lung
digest
singl
cell
suspens
incub
brefeldin
acontain
golgiplug
bd
bioscienc
six
hour
accord
manufactur
instruct
follow
stain
extracellular
antigen
intracellular
cytokin
stain
perform
use
cytofixcytoperm
system
bd
bioscienc
intracellular
antigen
granzym
b
stain
follow
permeabil
antibodi
purchas
bd
bioscienc
ebiosci
biolegend
kbsiinfekl
pentam
purchas
proimmun
influenza
npspecif
tetram
kindli
provid
dr
david
woodland
trudeau
institut
sampl
acquir
use
cytom
coulter
station
beckman
coulter
analyz
use
flow
jo
softwar
treestar
corp
whole
lung
homogen
pbsgelatin
cytokin
concentr
measur
beadbas
multiplex
elisa
millipor
use
luminex
luminex
corpor
serum
use
detect
circul
use
competit
estradiol
elisa
cayman
chemic
mice
infect
describ
viru
mock
infect
pb
target
cell
adopt
transfer
splenocyt
congen
naiv
donor
mous
use
target
cell
inject
intraven
ratio
two
popul
one
popul
incub
ova
peptid
siinfekl
label
cfse
second
popul
incub
irrelev
peptid
label
cfse
posttransf
mice
sacrif
spleen
recipi
mice
disrupt
suspend
red
blood
cell
lysi
buffer
total
spleen
analyz
flow
cytometri
rel
proport
cfselabel
cell
specif
kill
calcul
previous
describ
briefli
normal
valu
n
calcul
low
cfse
high
cfse
mock
infect
anim
treatment
group
percent
specif
cytotox
calcul
infect
mous
follow
low
cfse
x
n
high
cfse
low
cfse
x
n
x
spleen
oti
mice
mechan
disrupt
pass
strainer
cell
suspend
red
blood
cell
lysi
buffer
bd
bioscienc
wash
suspend
hbss
contain
fb
fcreceptor
block
bd
bioscienc
cell
incub
cocktail
biotinlabel
antibodi
includ
mhcii
cell
suspens
wash
incub
antibiotin
magnet
bead
pass
mac
magnet
column
miltenyi
biotec
flow
collect
verifi
flow
cytometri
puriti
greater
cfse
dilut
assay
cell
stain
cfse
label
cell
intraven
inject
recipi
mice
day
infect
mice
sacrif
lymph
node
collect
analysi
result
express
mean
standard
deviat
data
set
multipl
group
analyz
anova
follow
newmankeul
multipl
comparison
test
weight
loss
evalu
use
twoway
anova
singl
time
point
analys
evalu
use
unpair
twotail
student
test
p
valu
confid
consid
signific
data
analyz
graph
prepar
use
prism
softwar
